These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prevalence of hepatitis C virus (HCV) antibodies in haemodialysis patients. Vandelli L, Medici G, Savazzi AM, De Palma M, Lusvarghi E. Arch Virol Suppl; 1992; 4():339-42. PubMed ID: 1333330 [Abstract] [Full Text] [Related]
5. Hepatitis C virus infection in chronic haemodialysis patients, a clinicopathologic study. Alfurayh O, Sobh M, Buali A, Ali MA, Barri Y, Qunibi W, Taher S. Nephrol Dial Transplant; 1992; 7(4):327-32. PubMed ID: 1375712 [Abstract] [Full Text] [Related]
8. Non-A, non-B hepatitis: clinical laboratory course in patients on hemodialysis and its correlation with the presence of anti-hepatitis C virus antibodies. La Russa A, Bufano G, Cauzzi L, Pecchini P. Nephron; 1992; 61(3):273-5. PubMed ID: 1323770 [Abstract] [Full Text] [Related]
10. Prevalence and significance of antibodies to hepatitis C virus among Saudi haemodialysis patients. Ayoola EA, Huraib S, Arif M, al-Faleh FZ, al-Rashed R, Ramia S, al-Mofleh IA, Abu-Aisha H. J Med Virol; 1991 Nov; 35(3):155-9. PubMed ID: 1725179 [Abstract] [Full Text] [Related]
11. Antibodies against hepatitis C virus (anti-HCV) in haemodialysis patients: association with hepatitis B serological markers. Elisaf M, Tsianos E, Mavridis A, Dardamanis M, Pappas M, Siamopoulos KC. Nephrol Dial Transplant; 1991 Nov; 6(7):476-9. PubMed ID: 1717891 [Abstract] [Full Text] [Related]
17. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients. Yamaguchi K, Kiyokawa H, Machida J, Obayashi A, Nojiri N, Ueda S, Takatsuki K. FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023 [Abstract] [Full Text] [Related]